ARTICLE | Company News
Guilford, ProQuest Pharmaceuticals deal
December 6, 2004 8:00 AM UTC
GLFD will acquire Pro Quest for about $7 million in stock. The acquisition supersedes a 2000 deal between the companies under which GLFD received worldwide rights to Aquavan, an injectable prodrug fo...